Nationwide study of hospitalizations finds percutaneous coronary intervention is safe for cardio-oncology patients
WHO clears China’s CanSino COVID vaccine for emergency use
19 May 2022Immune sensor ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
19 May 2022Nationwide study of hospitalizations finds percutaneous coronary intervention is safe for cardio-oncology patients
New data from a study of more than 100 million hospitalizations using machine learning augmentation is being presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The findings reveal percutaneous coronary intervention (PCI) is safe and increasing among cancer patients.
